Mahmoud Hafez Joins Conformis Scientific Advisory Board to Advance Image to Implant Technology
Prof. Hafez brings rich history of development in patient specific orthopaedics to Conformis team
Burlington, Mass.— Sept 15, 2011 — Today, Conformis announced that Prof. Mahmoud Hafez has joined the Conformis Scientific Advisory Board. Dr. Hafez is a Professor of Orthopaedics and the Head of the Orthopaedic Department at October 6 University in Cairo, Egypt. He received his training in hip and knee arthroplasty via centers in the US, UK, Egypt and Canada and was an early pioneer in patient specific surgical instruments.
“It is exciting to see patient specific orthopaedics gaining increased acceptance in the field,” said Prof. Hafez. “Conformis is the leader in the use patient-specific approaches to orthopaedics, not just in instruments but in the actual implant design. I am excited by the opportunity to work on new enhancements to their image to implant technology.”
Prof. Hafez is an internationally recognized expert in the design and application of individual templates for orthopedics and in computer assisted orthopaedic surgery. He has served as faculty at international orthopaedic conferences including SICOT, ISTA, AAOS, and CAOS International. He is also the author of numerous articles and book chapters on computer assisted surgery and patient specific cutting guides for use in knee arthroplasty. In 2010, Prof. Hafez won the HAP Paul Award from ISTA for his work on the laboratory validation and clinical application of patient specific instruments for total knee replacement.
“I am extremely pleased that Professor Hafez has joined our Scientific Advisory Board,” said Philipp Lang, CEO of Conformis. “Professor Hafez has a rich base of knowledge and historical expertise in patient specific systems and we are thrilled that he will be working with us on future applications for our patient specific implant and instrument technology as well as clinical and scientific studies.”
About Conformis, Inc.
Conformis, Inc. is a privately-held company that develops and commercializes orthopedic devices for the treatment of musculoskeletal disorders. Its intellectual property includes more than 300 patents and patent applications in the areas of imaging software, image processing, implant design, surgical techniques, instrumentation, and manufacturing, spanning multiple joints. To date, Conformis has commercialized a line of US FDA cleared and CE Marked knee implant systems designed to address all stages of osteoarthritis, the most common reason for knee replacement surgery. Follow Conformis on Twitter at @Conformis and become a fan on Facebook at www.facebook.com/Conformis.
Conformis Announces FDA Clearance and Full Commercial Launch of Next Generation Hip System at the 2019 AAHKS Conference
Designed to enhance operational efficiency for the surgeon, the Conformis Hip System is the most advanced, patient-conforming hip replacement system
Conformis and Stryker Execute Development, License and Distribution Agreements
Deal to Cover Patient-Specific Instrumentation Used in Knee Arthroplasty BILLERICA, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ: CFMS), a medical technology